Surging volume of organ transplantation procedures, technological advancements in molecular diagnostics, genetic testing, identification of biomarkers, awareness among masses regarding the requirement for organ transplantation and supportive policies and regulations made by the government are some of the key trends bound to propel the transplant diagnostics market size. The demographic shift toward aging population is also necessitating the availability of efficient diagnostic tools to make organ matching in transplantation possible.
In line with the latest transplant diagnostics market trends, the industry is currently experiencing significant transformation, characterized by advancements in technology and an increasing emphasis on personalized medicine. Emerging technologies such as next-generation sequencing and molecular profiling are increasing the donor-recipient matching and accuracy of transplant success.
Machine learning and artificial intelligence are being used in diagnostics, which is improving workflows and data analysis. These trends render such increasing interest in optimizing patient benefit and consolidating the profession of transplant medicine relevant. Mergers and collaborations between top players of the industry is helping drive the pace for innovation as well as gain more market space, particularly in emerging economies.
Transplant diagnostics consists of a collection of medical testing techniques employed for assessing organ donor-recipient compatibility with the view of obtaining successful transplantation. Transplant diagnostics are useful in identifying potential immunological incompatibility as well as likelihood of transplant rejection.
One of the significant uses of transplant diagnostics is organ transplantation, where diagnosis tests confirm that the patient undergoing the organ is most compatible to a donor organ. For example, human leukocyte antigen (HLA) typing is a routine diagnosis test, which is aimed at identifying specific proteins that are present in cell membranes and primarily accountable for immunity.
By matching the donor and recipient based on their HLA types, physicians can prevent organ rejection to a significant extent. Additionally, in order to evaluate the transplant health of the recipient, non-invasive diagnostics such as circulating cell-free DNA (cfDNA) tests are employed for the quantification of donor-derived DNA in the recipient's blood.
| Attribute | Details |
|---|---|
| Market Drivers |
|
The growth rate of organ transplants has contributed drastically to transplant diagnostics market growth. With continuously increasing demand for organ transplantation due to demographics like aging population, increased incidence of chronic disease, and availability of advanced medical technology, the need for proper diagnostic machinery has also become increasingly significant. Transplant diagnostics has a significant role to play in organ transplant success by identifying donor and recipient compatibility, tracking the health of organs, and avoiding rejection.
While global statistics account for consistent increase in organ transplant procedures, physicians are increasingly relying on advanced diagnostic equipment to yield improved patient outcomes. Advances in the form of genetic screening, molecular diagnostics, and advanced imaging technology are being utilized to offer more precise predictions regarding organ compatibility and function.
Further, statistics from the Organ Procurement and Transplantation Network (OPTN) reveal that 48,149 organ transplants were reported in the U.S. in 2024. This represents a 3.3% increase in the number of transplantations as compared to 2023, and 23.3% rise over the past five years.
Expanding number of transplant programs across different geographies, specifically in developing countries, are also fueling the market's growth. The growing awareness regarding organ donation and transplantation, alongside public health initiatives, is instilling confidence within people to consider organ donation and subsequently boosting the pool of donors. The transplant diagnostic market therefore is witnessing a growth in investment made by both government and private firms, leading to enhancements in research and development activities.
One of the key driving forces in the transplant diagnostics market is growing awareness and the trend toward organ donation. The donor pool is increased as increasing numbers of people become aware of the life-saving potential of organ transplantation and are thus willing to sign up to become donors.
Institutions such as health organizations, non-profit organizations, and government organizations have been quite effective in campaigns regarding the significance of organ donation and dispelling common myths that people have associated with organ donation. This increased sensitivity not only provokes increased enrollments but also sparks a cultural transition to regard organ donation as a valuable component of civic responsibility.
With increasingly available donors, there comes the demand for advanced transplant diagnostics. Transplant diagnostics are required to match donors and recipients, assess the viability of organs, and monitor the success of transplants. Genomic analysis technologies, biomarker identification, and immunological profiling are increasingly important in a bid to deliver the best transplant outcomes.
Furthermore, the convergence of digital health technologies and social networking sites has enabled awareness campaigns regarding organ donation information to reach its widest audience to date. Beyond education of the masses, it encourages real-time discussion and personal accounts by recipients of transplants and donor families, thereby raising the positive impacts of donation.
The kits and reagents category dominates the transplant diagnostics market due to the central role such products play in facilitating effective donor-recipient matching. These products allow physicians to carry out necessary tests, including genetic tests and immunologic tests, necessary in prevention of organ rejection and facilitating maximum transplant success.
Their extensive application in hospitals and laboratories, in combination with advancements in technology that enhance the sensitivity and speed of tests, creates high demand. Additionally, the growing rate of organ transplants globally keeps driving demand for the diagnostic kits and reagents, rendering them the crux of transplant surgeries.
Molecular assay segment of the transplant diagnostics market holds the major share owing to its ability to provide highly sensitive and specific results for donor-recipient compatibility testing.
Molecular tests are important in the identification of infectious agents and potential rejection risks because they analyze DNA, RNA, and proteins. The use of molecular assays has risen with the increased application of newer molecular methods such as next-generation sequencing (NGS) and polymerase chain reaction (PCR). Molecular assay market is also expected to continue driving market growth as the transplant process advances and becomes more individualized.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest transplant diagnostics market report, North America dominated with the highest share in 2024. This can be ascribed to the region's superior healthcare infrastructure, a high level of investment in research and development, leading to innovative diagnostic technologies. The demand for organ transplant is being fueled by the rising prevalence of chronic diseases in the region, such as diabetes and kidney failure, which in turn is fueling demand for efficient diagnostic technology.
The U.S. dominates the market for transplant diagnostics in North America owing to the country's highly advanced healthcare infrastructure and a high level of research investment in the medical sector. A strong presence of top diagnostic companies and advanced technologies has established the U.S. at the top of transplant diagnostics.
In addition, stringent regulatory guidelines and large transplant networks promise to embrace advanced diagnostic solutions. The focus on delivering the highest possible patient care through tailored medicine and continuous innovation in laboratory techniques further strengthen the U.S. leadership position in North America's transplant diagnostics market .
Key players in the transplant diagnostics industry are forming strategic collaborations to conduct targeted research initiatives. Furthermore, companies are expanding their operations to developing nations, where the volume of transplant procedures is expected to increase remarkably in the coming years. These initiatives are playing a crucial role in fostering innovation and driving market expansion.
Abbott, Bio-Rad Laboratories, Inc., QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, Inc., Siemens Healthineers, Agilent Technologies, Inc., Takara Bio Inc., Hologic, Inc., Werfen, S.A., and DiaSorin S.p.A. are some of the leading key players operating in the global transplant diagnostics market.
Each of these players have been have been profiled in the transplant diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Details |
|---|---|
| Size in 2024 | US$ 7.8 Bn |
| Forecast Value in 2035 | US$ 17.2 Bn |
| CAGR | 7.3% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Bn |
| Transplant Diagnostics Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global transplant diagnostics market was valued at US$ 7.8 Bn in 2024.
The global transplant diagnostics business is projected to reach more than US$ 17.2 Bn by the end of 2035.
Rising incidence of organ transplants and technological innovations in diagnostic technologies.
The CAGR is anticipated to be 7.3% from 2025 to 2035.
Abbott, Bio-Rad Laboratories, Inc., QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, Inc., Siemens Healthineers, Agilent Technologies, Inc., Takara Bio Inc., Hologic, Inc., Werfen, S.A. and DiaSorin S.p.A. are the prominent players in the transplant diagnostics market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transplant Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017 to 2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Screening, 2017 to 2031
6.3.1. Pre-transplant Diagnostics
6.3.2. Post-transplant Diagnostics
6.4. Market Attractiveness, by Screening
7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017 to 2031
7.3.1. Molecular Assay
7.3.2. Non-molecular Assay
7.3.3. 7.4 Market Attractiveness, by Technique
8. Global Transplant Diagnostics Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017 to 2031
8.3.1. Solid Organ Transplantation
8.3.1.1. Kidney
8.3.1.2. Liver
8.3.1.3. Heart
8.3.1.4. Lungs
8.3.1.5. Pancreas
8.3.1.6. Small Bowel
8.3.2. Stem Cell Transplantation
8.4. Market Attractiveness, by Application
9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Products & Services, 2017 to 2031
9.3.1. Reagents & Consumables
9.3.2. Instruments
9.3.3. Software & Services
9.4. Market Attractiveness, by Products & Services
10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017 to 2031
10.3.1. Hospitals & Transplant Centers
10.3.2. Research Laboratories
10.3.3. Others
10.4. Market Attractiveness, by End-user
11. Global Transplant Diagnostics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017 to 2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Transplant Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Screening, 2017 to 2031
12.2.1. Pre-transplant Diagnostics
12.2.2. Post-transplant Diagnostics
12.3. Market Attractiveness, by Screening
12.4. Market Value Forecast, by Technique, 2017 to 2031
12.4.1. Molecular Assay
12.4.2. Non-molecular Assay
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Application, 2017 to 2031
12.6.1. Solid Organ Transplantation
12.6.1.1. Kidney
12.6.1.2. Liver
12.6.1.3. Heart
12.6.1.4. Lungs
12.6.1.5. Pancreas
12.6.1.6. Small Bowel
12.6.2. Stem Cell Transplantation
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by Products & Services, 2017 to 2031
12.8.1. Reagents & Consumables
12.8.2. Instruments
12.8.3. Software & Services
12.9. Market Attractiveness, by Products & Services
12.10. Market Value Forecast, by End-user, 2017 to 2031
12.10.1. Hospitals & Transplant Centers
12.10.2. Research Laboratories
12.10.3. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Screening
12.13.2. By Technique
12.13.3. By Application
12.13.4. By Products & Services
12.13.5. By End-user
12.13.6. By Country
13. Europe Transplant Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Screening, 2017 to 2031
13.2.1. Pre-transplant Diagnostics
13.2.2. Post-transplant Diagnostics
13.3. Market Attractiveness, by Screening
13.4. Market Value Forecast, by Technique, 2017 to 2031
13.4.1. Molecular Assay
13.4.2. Non-molecular Assay
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Application, 2017 to 2031
13.6.1. Solid Organ Transplantation
13.6.1.1. Kidney
13.6.1.2. Liver
13.6.1.3. Heart
13.6.1.4. Lungs
13.6.1.5. Pancreas
13.6.1.6. Small Bowel
13.6.2. Stem Cell Transplantation
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by Products & Services, 2017 to 2031
13.8.1. Reagents & Consumables
13.8.2. Instruments
13.8.3. Software & Services
13.9. Market Attractiveness, by Products & Services
13.10. Market Value Forecast, by End-user, 2017 to 2031
13.10.1. Hospitals & Transplant Centers
13.10.2. Research Laboratories
13.10.3. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Screening
13.13.2. By Technique
13.13.3. By Application
13.13.4. By Products & Services
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Screening, 2017 to 2031
14.2.1. Pre-transplant Diagnostics
14.2.2. Post-transplant Diagnostics
14.3. Market Attractiveness, by Screening
14.4. Market Value Forecast, by Technique, 2017 to 2031
14.4.1. Molecular Assay
14.4.2. Non-molecular Assay
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Application, 2017 to 2031
14.6.1. Solid Organ Transplantation
14.6.1.1. Kidney
14.6.1.2. Liver
14.6.1.3. Heart
14.6.1.4. Lungs
14.6.1.5. Pancreas
14.6.1.6. Small Bowel
14.6.2. Stem Cell Transplantation
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by Products & Services, 2017 to 2031
14.8.1. Reagents & Consumables
14.8.2. Instruments
14.8.3. Software & Services
14.9. Market Attractiveness, by Products & Services
14.10. Market Value Forecast, by End-user, 2017 to 2031
14.10.1. Hospitals & Transplant Centers
14.10.2. Research Laboratories
14.10.3. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Screening
14.13.2. By Technique
14.13.3. By Application
14.13.4. By Products & Services
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Transplant Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Screening, 2017 to 2031
15.2.1. Pre-transplant Diagnostics
15.2.2. Post-transplant Diagnostics
15.3. Market Attractiveness, by Screening
15.4. Market Value Forecast, by Technique, 2017 to 2031
15.4.1. Molecular Assay
15.4.2. Non-molecular Assay
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Application, 2017 to 2031
15.6.1. Solid Organ Transplantation
15.6.1.1. Kidney
15.6.1.2. Liver
15.6.1.3. Heart
15.6.1.4. Lungs
15.6.1.5. Pancreas
15.6.1.6. Small Bowel
15.6.2. Stem Cell Transplantation
15.7. Stem Cell Transplantation Market Attractiveness, by Application
15.8. Market Value Forecast, by Products & Services, 2017 to 2031
15.8.1. Reagents & Consumables
15.8.2. Instruments
15.8.3. Software & Services
15.9. Market Attractiveness, by Products & Services
15.10. Market Value Forecast, by End-user, 2017 to 2031
15.10.1. Hospitals & Transplant Centers
15.10.2. Research Laboratories
15.10.3. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Screening
15.13.2. By Technique
15.13.3. By Application
15.13.4. By Products & Services
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Screening, 2017 to 2031
16.2.1. Pre-transplant Diagnostics
16.2.2. Post-transplant Diagnostics
16.3. Market Attractiveness, by Screening
16.4. Market Value Forecast, by Technique, 2017 to 2031
16.4.1. Molecular Assay
16.4.2. Non-molecular Assay
16.5. Market Attractiveness, by Technique
16.6. Market Value Forecast, by Application, 2017 to 2031
16.6.1. Solid Organ Transplantation
16.6.1.1. Kidney
16.6.1.2. Liver
16.6.1.3. Heart
16.6.1.4. Lungs
16.6.1.5. Pancreas
16.6.1.6. Small Bowel
16.6.2. Stem Cell Transplantation
16.7. Market Attractiveness, by Application
16.8. Market Value Forecast, by Products & Services, 2017 to 2031
16.8.1. Reagents & Consumables
16.8.2. Instruments
16.8.3. Software & Services
16.9. Market Attractiveness, by Products & Services
16.10. Market Value Forecast, by End-user, 2017 to 2031
16.10.1. Hospitals & Transplant Centers
16.10.2. Research Laboratories
16.10.3. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Screening
16.13.2. By Technique
16.13.3. By Application
16.13.4. By Products & Services
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Bio-Rad laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Qiagen N.V.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. F. Hoffmann-La Roche AG
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Thermo Fisher Scientific, Inc.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Becton, Dickinson and Company
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Ortho Clinical Diagnostics
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Immucor, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Illumina, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Siemens Healthineers (Siemens AG)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Agilent Technologies
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
List of Tables
Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017 to 2031
Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017 to 2031
Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
List of Figures
Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017 to 2031
Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023 to 2031
Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023 to 2031
Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Transplant Diagnostics Market
